Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Interest & Investment Income: 2018-2023

Historic Interest & Investment Income for Silence Therapeutics (SLN) over the last 6 years, with Dec 2023 value amounting to $1.8 million.

  • Silence Therapeutics' Interest & Investment Income fell 50.82% to $1.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.1 million, marking a year-over-year increase of 404.01%. This contributed to the annual value of $1.8 million for FY2023, which is 14.25% up from last year.
  • As of FY2023, Silence Therapeutics' Interest & Investment Income stood at $1.8 million, which was up 14.25% from $1.6 million recorded in FY2022.
  • In the past 5 years, Silence Therapeutics' Interest & Investment Income registered a high of $1.8 million during FY2023, and its lowest value of $13,759 during FY2021.
  • Its 3-year average for Interest & Investment Income is $1.1 million, with a median of $1.6 million in 2022.
  • As far as peak fluctuations go, Silence Therapeutics' Interest & Investment Income plummeted by 91.69% in 2021, and later spiked by 11,341.69% in 2022.
  • Yearly analysis of 5 years shows Silence Therapeutics' Interest & Investment Income stood at $34,475 in 2019, then spiked by 380.51% to $165,655 in 2020, then tumbled by 91.69% to $13,759 in 2021, then spiked by 11,341.69% to $1.6 million in 2022, then increased by 14.25% to $1.8 million in 2023.